Debt-to-equity improved to 1.09 from 1.83 and cash rebuilt to $717.8M, but total debt of $2.4B and goodwill of roughly $2.5B against a $6.3B asset base indicate a leveraged, acquisition-heavy capital structure.
BrightSpring Health Services, Inc. Common Stock (BTSG) balance sheet — 7-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 |
|---|
| Total Current Assets | 2.77B | 2.89B | 1.89B | 1.46B | 1.34B | 1.18B | 1.29B | 870.68M |
| Cash & Short-Term Investments | 717.84M | 88.37M | 61.25M | 13.07M | 13.63M | 46.73M | 262M | 18.3M |
| Cash Only | 717.84M | 88.37M | 61.25M | 13.07M | 13.63M | 46.73M | 262M | 18.3M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.22B | 1.07B | 1.15B | 1.01B | 868.35M | 805M | 700.84M | 622.28M |
| Days Sales Outstanding | 28.76 | 30.31 | 37.23 | 41.8 | 41.05 | 43.87 | 45.84 | 50.19 |
| Inventory | 671.59M | 815.18M | 640.57M | 402.78M | 430.52M | 299.22M | 300.06M | 198.47M |
| Days Inventory Outstanding | 17.93 | 26.12 | 24.16 | 19.89 | 24.68 | 20.04 | 24.17 | 19.63 |
| Other Current Assets | 159.95M | 899.01M | 24.59M | 13.19M | 13.51M | 12.66M | 16.41M | 23.37M |
| Total Non-Current Assets | 3.5B | 3.52B | 4.03B | 4.08B | 4.1B | 4.33B | 3.25B | 2.95B |
| Property, Plant & Equipment | 383.51M | 376.32M | 500.03M | 513.35M | 475.27M | 524.64M | 450.71M | 432.55M |
| Fixed Asset Turnover | 40.24x | 34.31x | 22.53x | 17.19x | 16.24x | 12.77x | 12.38x | 10.46x |
| Goodwill | 2.54B | 2.55B | 2.67B | 2.61B | 2.58B | 2.66B | 1.67B | 1.41B |
| Intangible Assets | 491.66M | 557.55M | 811.48M | 881.48M | 975.86M | 1.11B | 1.1B | 1.07B |
| Long-Term Investments | 84.89M | 8.2M | 670K | 720K | 736K | 2.66M | 2.48M | 2.37M |
| Other Non-Current Assets | 53.6M | 31.51M | 43.8M | 72.12M | 68.93M | 35.78M | 32.22M | 34.56M |
| Total Assets | 6.27B | 6.41B | 5.93B | 5.53B | 5.44B | 5.51B | 4.54B | 3.82B |
| Asset Turnover | 2.45x | 2.01x | 1.90x | 1.60x | 1.42x | 1.21x | 1.23x | 1.19x |
| Asset Growth % | 18.78% | 8.22% | 7.11% | 1.68% | -1.31% | 21.41% | 18.96% | - |
| Total Current Liabilities | 1.71B | 1.85B | 1.43B | 1.25B | 932.51M | 892.16M | 742.79M | 621.97M |
| Accounts Payable | 1.23B | 1.22B | 941.29M | 641.61M | 526.92M | 408.11M | 355.75M | 252.75M |
| Days Payables Outstanding | 31.68 | 39.02 | 35.5 | 31.68 | 30.21 | 27.33 | 28.65 | 24.99 |
| Short-Term Debt | 35.28M | 52.34M | 48.73M | 32.27M | 30.41M | 40.54M | 22.5M | 18.48M |
| Deferred Revenue (Current) | 42.34M | 9.04M | 11M | 30.85M | 29.04M | 10.49M | 22.76M | 3.31M |
| Other Current Liabilities | 86.74M | 297.19M | 98.84M | 118.14M | 80.73M | 95.87M | 16.18M | 14.19M |
| Current Ratio | 1.62x | 1.57x | 1.33x | 1.17x | 1.44x | 1.32x | 1.74x | 1.40x |
| Quick Ratio | 1.22x | 1.12x | 0.88x | 0.84x | 0.98x | 0.99x | 1.33x | 1.08x |
| Cash Conversion Cycle | 15.01 | 17.41 | 25.89 | 30.01 | 35.53 | 36.57 | 41.35 | 44.83 |
| Total Non-Current Liabilities | 2.37B | 2.68B | 2.85B | 3.67B | 3.72B | 3.82B | 3.06B | 2.49B |
| Long-Term Debt | 2.15B | 2.46B | 2.56B | 3.33B | 3.36B | 3.39B | 2.67B | 2.16B |
| Capital Lease Obligations | 589.67M | 149.96M | 212.6M | 224.18M | 204.91M | 252.09M | 211.95M | 190.15M |
| Deferred Tax Liabilities | 18.32M | 6.18M | 0 | 23.67M | 79.39M | 98.16M | 121.64M | 65.68M |
| Other Non-Current Liabilities | 68.23M | 66.56M | 71.76M | 91.94M | 75.94M | 77.04M | 57.98M | 65.46M |
| Total Liabilities | 4.08B | 4.53B | 4.27B | 4.92B | 4.66B | 4.71B | 3.81B | 3.11B |
| Total Debt | 2.38B | 2.71B | 2.9B | 3.67B | 3.68B | 3.77B | 2.97B | 2.44B |
| Net Debt | 1.66B | 2.62B | 2.84B | 3.66B | 3.66B | 3.72B | 2.71B | 2.43B |
| Debt / Equity | 1.09x | 1.44x | 1.76x | 5.99x | 4.69x | 4.71x | 4.04x | 3.44x |
| Debt / EBITDA | 3.35x | 5.89x | 7.07x | 10.50x | 9.39x | 8.70x | 8.58x | 11.20x |
| Net Debt / EBITDA | 2.34x | 5.70x | 6.92x | 10.46x | 9.35x | 8.59x | 7.82x | 11.12x |
| Interest Coverage | 3.80x | 1.88x | 0.85x | 0.45x | 0.80x | 1.42x | 1.19x | 0.38x |
| Total Equity | 2.19B | 1.89B | 1.65B | 612.55M | 784.08M | 800.46M | 735.38M | 710.23M |
| Equity Growth % | 69.87% | 14.22% | 169.63% | -21.88% | -2.05% | 8.85% | 3.54% | - |
| Book Value per Share | 9.93 | 8.58 | 8.56 | 3.58 | 4.58 | 4.68 | 4.30 | 4.15 |
| Total Shareholders' Equity | 2.18B | 1.88B | 1.65B | 584.74M | 754.78M | 774.82M | 704.98M | 656.87M |
| Common Stock | 1.99M | 1.92M | 1.74M | 1.18M | 1.18M | 1.18M | 745.17M | 745.88M |
| Retained Earnings | 138.57M | -74.65M | -222.16M | -200.32M | -45.72M | 971K | -51.75M | -94.28M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 14.1M | -6.69M | 1.42M | 12.54M | 21.19M | 217K | 185K | 132K |
| Minority Interest | 9.28M | 11.3M | 3.73M | 27.81M | 29.31M | 25.65M | 30.39M | 53.36M |
Quick answers to the most common questions about buying BTSG stock.
As of 2025, BrightSpring Health Services, Inc. Common Stock (BTSG) had total assets of $6.41B including $2.89B in current assets.
BrightSpring Health Services, Inc. Common Stock (BTSG) carries total debt of $2.71B, offset by $88.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
BrightSpring Health Services, Inc. Common Stock (BTSG) has total shareholders' equity (book value) of $1.88B ($8.58 book value per share). Book value represents the net worth of the company belonging to common stock holders.
BrightSpring Health Services, Inc. Common Stock (BTSG) reported a current ratio of 1.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Leverage against thin margins
Metrics are mathematically derived from official filings.
Equity Rebuilds as Deficit Reverses
According to the reported quarterly figures, BTSG's retained earnings moved from a deficit of $234.4M in 2024Q3 to a positive $138.6M in 2026Q3, while equity roughly doubled to $2.2B over the same period, signaling genuine balance sheet repair.
The swing into positive retained earnings suggests recent profitability has begun to absorb the accumulated losses that characterized the private-ownership era. Much of the equity build appears tied to the public listing and earnings recovery rather than asset growth alone. Investors should monitor whether earnings consistency holds, since the trajectory depends on sustained net income rather than one-time items.
Leverage Easing but Still Elevated
Based on reported figures, BTSG's debt-to-equity ratio fell from 1.83 in 2024Q3 to 1.09 in 2026Q3, while total debt held near $2.4B, indicating that deleveraging has come mainly from equity growth rather than debt repayment.
Because total debt remained roughly flat while equity expanded, the improvement in D/E appears driven by the denominator rather than meaningful principal reduction. Leverage at these levels leaves limited flexibility if reimbursement rates or labor costs move adversely. The reported debt-to-equity figure of 1.09 warrants further verification against the debt schedule before it is used in interest coverage modeling.
Cash Buffer Rebuilt Within Recent Quarters
As reported in financial statements, BTSG's cash balance climbed from $25.0M in 2024Q2 to $717.8M in 2026Q3, while the current ratio held in a 1.6 to 1.8 range since 2025, suggesting a materially stronger near-term liquidity position.
The jump in cash appears to reflect the post-listing capital position and improved cash generation rather than a structural change in working capital. A current ratio near 1.6 indicates adequate coverage of short-term obligations without excess slack. The sharp quarter-to-quarter cash volatility in 2025 and early 2026 suggests timing effects that the buffer should be assessed against over a full cycle.
Goodwill-Heavy Asset Base Persists
Based on reported figures, BTSG's goodwill of roughly $2.5B and net PPE of $383.5M together represent a large share of the $6.3B asset base, indicating an asset profile dominated by acquired intangibles rather than physical capacity.
A goodwill balance this large relative to total assets implies that future impairment risk is a meaningful consideration if acquired businesses underperform their purchase assumptions. The PPE line rose sharply in late 2024, which appears linked to acquisition activity rather than organic capital investment. The asset-light operating character, combined with significant intangibles, makes the reported book equity sensitive to acquisition accounting judgments.
Deleveraging Narrative Rests on Equity
According to the quarterly data, the improvement in D/E from 1.83 to 1.09 is mostly a function of rising equity, since total debt barely moved from $3.0B to $2.4B, which may overstate the degree of true balance sheet repair.
If the equity rebuild partly reflects non-recurring items or favorable tax effects, the apparent leverage improvement may not be durable. Debt still represents a large multiple of operating earnings given the thin 1.5% net margin. Investors should treat the reported deleveraging as directionally positive while confirming that debt servicing capacity, not book equity, is driving the improved picture.